AAPL302.22+7.84 (+2.66%) ▲|ABBV254.12+3.06 (+1.22%) ▲|ABT92.26+0.08 (+0.09%) ▲|ACN134.93+3.80 (+2.90%) ▲|ADBE218.27+7.29 (+3.45%) ▲|AMAT643.04-7.87 (-1.21%) ▼|AMD536.49-4.39 (-0.81%) ▼|AMGN368.12+6.79 (+1.88%) ▲|AMT168.16+2.08 (+1.25%) ▲|AMZN243.25+1.55 (+0.64%) ▲|AVGO371.12+1.78 (+0.48%) ▲|AXP347.44+0.39 (+0.11%) ▲|BA226.81+8.23 (+3.77%) ▲|BAC58.13-0.23 (-0.39%) ▼|BKNG183.59+0.95 (+0.52%) ▲|BLK993.05+12.67 (+1.29%) ▲|BMY57.29+1.48 (+2.64%) ▲|BNY146.75+0.73 (+0.50%) ▲|BRK-B502.35+2.61 (+0.52%) ▲|C140.79+0.66 (+0.47%) ▲|CAT996.12+4.71 (+0.48%) ▲|CL93.74+0.98 (+1.06%) ▲|CMCSA23.66-0.08 (-0.32%) ▼|COF205.69+0.87 (+0.42%) ▲|COP104.22+1.00 (+0.97%) ▲|COST928.04+3.37 (+0.36%) ▲|CRM164.80+1.57 (+0.96%) ▲|CSCO115.66-1.36 (-1.16%) ▼|CVS104.58-0.23 (-0.22%) ▼|CVX168.85+3.16 (+1.91%) ▲|DE637.07+9.44 (+1.50%) ▲|DHR195.65+1.93 (+1.00%) ▲|DIS95.91+0.20 (+0.21%) ▲|DUK126.61+0.84 (+0.67%) ▲|EMR141.47+1.95 (+1.40%) ▲|FDX314.92+1.03 (+0.33%) ▲|GD368.81+6.02 (+1.66%) ▲|GE380.72+5.79 (+1.54%) ▲|GEV1,129.86-4.87 (-0.43%) ▼|GILD127.56+1.59 (+1.26%) ▲|GM75.95+0.41 (+0.54%) ▲|GOOG360.11+2.22 (+0.62%) ▲|GOOGL363.47+2.26 (+0.63%) ▲|GS1,036.49+16.78 (+1.65%) ▲|HD349.32-1.58 (-0.45%) ▼|HON223.68+1.93 (+0.87%) ▲|IBM289.12+2.85 (+1.00%) ▲|INTC129.09+2.07 (+1.63%) ▲|INTU271.60+4.52 (+1.69%) ▲|ISRG411.44+9.06 (+2.25%) ▲|JNJ256.99+3.04 (+1.20%) ▲|JPM332.92-1.16 (-0.35%) ▼|KO81.63+0.32 (+0.39%) ▲|LIN540.54+6.99 (+1.31%) ▲|LLY1,208.63+16.72 (+1.40%) ▲|LMT538.92+17.22 (+3.30%) ▲|LOW222.13+0.26 (+0.12%) ▲|LRCX384.51-6.75 (-1.73%) ▼|MA527.43+4.93 (+0.94%) ▲|MCD272.63+3.16 (+1.17%) ▲|MDLZ60.15+0.80 (+1.35%) ▲|MDT80.04+0.83 (+1.05%) ▲|META592.61-20.30 (-3.31%) ▼|MMM160.82+0.77 (+0.48%) ▲|MO72.28+0.72 (+1.01%) ▲|MRK127.22+1.81 (+1.44%) ▲|MS214.77+2.92 (+1.38%) ▲|MSFT385.47+1.19 (+0.31%) ▲|MU1,056.49+24.21 (+2.35%) ▲|NEE86.90+0.51 (+0.59%) ▲|NFLX75.51+1.32 (+1.78%) ▲|NKE44.70+1.56 (+3.60%) ▲|NOW105.74-0.03 (-0.03%) ▼|NVDA197.98+0.40 (+0.20%) ▲|ORCL145.80+3.07 (+2.15%) ▲|PEP142.82+1.66 (+1.18%) ▲|PFE24.33+0.44 (+1.82%) ▲|PG148.47+1.03 (+0.70%) ▲|PLTR130.68+4.95 (+3.94%) ▲|PM180.90+3.22 (+1.81%) ▲|QCOM182.72+0.80 (+0.44%) ▲|RTX196.83+5.06 (+2.64%) ▲|SBUX103.76+0.37 (+0.35%) ▲|SCHW96.46+0.69 (+0.72%) ▲|SO95.68+0.55 (+0.57%) ▲|SPG223.60+0.51 (+0.23%) ▲|T20.89+0.40 (+1.93%) ▲|TMO520.70+7.20 (+1.40%) ▲|TMUS176.00+2.94 (+1.70%) ▲|TSLA412.61-12.69 (-2.98%) ▼|TXN303.63+5.22 (+1.75%) ▲|UBER73.32+0.65 (+0.89%) ▲|UNH429.13+2.70 (+0.63%) ▲|UNP281.81+4.10 (+1.47%) ▲|UPS110.54+1.04 (+0.95%) ▲|USB61.99+0.03 (+0.05%) ▲|V354.78+3.68 (+1.05%) ▲|VZ42.81+0.82 (+1.95%) ▲|WFC85.72-0.23 (-0.26%) ▼|WMT110.79+1.97 (+1.81%) ▲|XOM138.51+2.23 (+1.63%) ▲|AAPL302.22+7.84 (+2.66%) ▲|ABBV254.12+3.06 (+1.22%) ▲|ABT92.26+0.08 (+0.09%) ▲|ACN134.93+3.80 (+2.90%) ▲|ADBE218.27+7.29 (+3.45%) ▲|AMAT643.04-7.87 (-1.21%) ▼|AMD536.49-4.39 (-0.81%) ▼|AMGN368.12+6.79 (+1.88%) ▲|AMT168.16+2.08 (+1.25%) ▲|AMZN243.25+1.55 (+0.64%) ▲|AVGO371.12+1.78 (+0.48%) ▲|AXP347.44+0.39 (+0.11%) ▲|BA226.81+8.23 (+3.77%) ▲|BAC58.13-0.23 (-0.39%) ▼|BKNG183.59+0.95 (+0.52%) ▲|BLK993.05+12.67 (+1.29%) ▲|BMY57.29+1.48 (+2.64%) ▲|BNY146.75+0.73 (+0.50%) ▲|BRK-B502.35+2.61 (+0.52%) ▲|C140.79+0.66 (+0.47%) ▲|CAT996.12+4.71 (+0.48%) ▲|CL93.74+0.98 (+1.06%) ▲|CMCSA23.66-0.08 (-0.32%) ▼|COF205.69+0.87 (+0.42%) ▲|COP104.22+1.00 (+0.97%) ▲|COST928.04+3.37 (+0.36%) ▲|CRM164.80+1.57 (+0.96%) ▲|CSCO115.66-1.36 (-1.16%) ▼|CVS104.58-0.23 (-0.22%) ▼|CVX168.85+3.16 (+1.91%) ▲|DE637.07+9.44 (+1.50%) ▲|DHR195.65+1.93 (+1.00%) ▲|DIS95.91+0.20 (+0.21%) ▲|DUK126.61+0.84 (+0.67%) ▲|EMR141.47+1.95 (+1.40%) ▲|FDX314.92+1.03 (+0.33%) ▲|GD368.81+6.02 (+1.66%) ▲|GE380.72+5.79 (+1.54%) ▲|GEV1,129.86-4.87 (-0.43%) ▼|GILD127.56+1.59 (+1.26%) ▲|GM75.95+0.41 (+0.54%) ▲|GOOG360.11+2.22 (+0.62%) ▲|GOOGL363.47+2.26 (+0.63%) ▲|GS1,036.49+16.78 (+1.65%) ▲|HD349.32-1.58 (-0.45%) ▼|HON223.68+1.93 (+0.87%) ▲|IBM289.12+2.85 (+1.00%) ▲|INTC129.09+2.07 (+1.63%) ▲|INTU271.60+4.52 (+1.69%) ▲|ISRG411.44+9.06 (+2.25%) ▲|JNJ256.99+3.04 (+1.20%) ▲|JPM332.92-1.16 (-0.35%) ▼|KO81.63+0.32 (+0.39%) ▲|LIN540.54+6.99 (+1.31%) ▲|LLY1,208.63+16.72 (+1.40%) ▲|LMT538.92+17.22 (+3.30%) ▲|LOW222.13+0.26 (+0.12%) ▲|LRCX384.51-6.75 (-1.73%) ▼|MA527.43+4.93 (+0.94%) ▲|MCD272.63+3.16 (+1.17%) ▲|MDLZ60.15+0.80 (+1.35%) ▲|MDT80.04+0.83 (+1.05%) ▲|META592.61-20.30 (-3.31%) ▼|MMM160.82+0.77 (+0.48%) ▲|MO72.28+0.72 (+1.01%) ▲|MRK127.22+1.81 (+1.44%) ▲|MS214.77+2.92 (+1.38%) ▲|MSFT385.47+1.19 (+0.31%) ▲|MU1,056.49+24.21 (+2.35%) ▲|NEE86.90+0.51 (+0.59%) ▲|NFLX75.51+1.32 (+1.78%) ▲|NKE44.70+1.56 (+3.60%) ▲|NOW105.74-0.03 (-0.03%) ▼|NVDA197.98+0.40 (+0.20%) ▲|ORCL145.80+3.07 (+2.15%) ▲|PEP142.82+1.66 (+1.18%) ▲|PFE24.33+0.44 (+1.82%) ▲|PG148.47+1.03 (+0.70%) ▲|PLTR130.68+4.95 (+3.94%) ▲|PM180.90+3.22 (+1.81%) ▲|QCOM182.72+0.80 (+0.44%) ▲|RTX196.83+5.06 (+2.64%) ▲|SBUX103.76+0.37 (+0.35%) ▲|SCHW96.46+0.69 (+0.72%) ▲|SO95.68+0.55 (+0.57%) ▲|SPG223.60+0.51 (+0.23%) ▲|T20.89+0.40 (+1.93%) ▲|TMO520.70+7.20 (+1.40%) ▲|TMUS176.00+2.94 (+1.70%) ▲|TSLA412.61-12.69 (-2.98%) ▼|TXN303.63+5.22 (+1.75%) ▲|UBER73.32+0.65 (+0.89%) ▲|UNH429.13+2.70 (+0.63%) ▲|UNP281.81+4.10 (+1.47%) ▲|UPS110.54+1.04 (+0.95%) ▲|USB61.99+0.03 (+0.05%) ▲|V354.78+3.68 (+1.05%) ▲|VZ42.81+0.82 (+1.95%) ▲|WFC85.72-0.23 (-0.26%) ▼|WMT110.79+1.97 (+1.81%) ▲|XOM138.51+2.23 (+1.63%) ▲|
34.6 C
New York
Thursday, July 2, 2026

Tag: research

newssourceFORcompanyinformationcontent1releasesmarket

HTX Hot Listings Weekly Recap (July 21 – 28): SOL Memes & ETH DeFi Drive Market Surge, New Assets on HTX Post Impressive  Gains

HTX Hot Listings Weekly Recap

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader

Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun...

Chromatography Resin Market worth $4.94 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 1, 2025 /PRNewswire/ -- The report "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity...

Chromatography Resin Market worth $4.94 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 1, 2025 /PRNewswire/ -- The report "Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity...

Atombeat and BioDuro Announce Strategic Partnership to Launch an AI-Powered Platform for Accelerated Peptide Drug Discovery

SAN DIEGO, Aug. 1, 2025 /PRNewswire/ -- On July 30, 2025, Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a...

Avantor® Reports Second Quarter 2025 Results

Net sales of $1.68 billion, decrease of 1%; organic revenue was flatNet income of $65 million; Adjusted EBITDA of $280 millionDiluted GAAP EPS of...

PMI Calls for Ongoing G2G Dialogues with Source and Transit Countries to Combat Illicit Tobacco Trade

- India faces an annual loss of approximately $1.65 billion, with 25% of the domestic market illicit and an estimated 12,000 jobs lost each...

The Government of Odisha and the Singapore-headquartered Global Finance & Technology Network (GFTN) partner to develop an Integrated Global Financial Technology Capability Hub in...

Applications Open for National University of Singapore - Asian Institute of Digital Finance (NUS-AIDF) Certificate in FinTech & InsurTech for Odisha-based Students.   BHUBANESWAR, India, Aug....

Adhesives and Sealants Market Size Worth USD 126.50 Bn by 2034 Driven by Green Construction and Automotive Trends

The global adhesives and sealants market size is expected to be worth USD 126.50 billion by 2034, increasing from USD 76.53 billion in 2025 and is growing at a CAGR of 5.75% from 2025 to 2034, fueled by green construction, EV adoption, and packaging innovations. 
The global adhesives and sealants market size is expected to be worth USD 126.50 billion by 2034, increasing from USD 76.53 billion in 2025 and is growing at a CAGR of 5.75% from 2025 to 2034, fueled by green construction, EV adoption, and packaging innovations.

Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases

Embracing Innovation in Tenosynovitis Treatment: The global Tenosynovitis market is advancing rapidly, driven by the rising prevalence of inflammatory diseases like rheumatoid arthritis. As aging populations increase, demand grows for effective treatments to manage this tendon sheath inflammation. Biologic and targeted therapies, including TNF and IL-6 inhibitors, are at the forefront, alongside non-invasive options like PRP therapy. Leading companies such as Pfizer and AbbVie are fueling innovation with personalized medicine, addressing challenges of early diagnosis and treatment accessibility. Discover the future of tenosynovitis care and market trends shaping this evolving landscape. 
Embracing Innovation in Tenosynovitis Treatment: The global Tenosynovitis market is advancing rapidly, driven by the rising prevalence of inflammatory diseases like rheumatoid arthritis. As aging populations increase, demand grows for effective treatments to manage this tendon sheath inflammation. Biologic and targeted therapies, including TNF and IL-6 inhibitors, are at the forefront, alongside non-invasive options like PRP therapy. Leading companies such as Pfizer and AbbVie are fueling innovation with personalized medicine, addressing challenges of early diagnosis and treatment accessibility. Discover the future of tenosynovitis care and market trends shaping this evolving landscape.

Oculis Upsized Loan Facility to Access up to CHF 100 million

ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced that it has amended its loan facility (the “Amended Loan Agreement”) with funds and accounts managed by BlackRock (the “Lender”).

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson’s Disease

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational...

Zoe Energy Storage Secures BNEF Tier 1 Ranking Again

One-Stop Global Services Accelerate Green Transition Worldwide SHANGHAI, Aug. 1, 2025 /PRNewswire/ -- BloombergNEF (BNEF), the globally recognized authority in clean energy research, today released...

Herbalgy Trophy Wraps Up with a Thrilling 1-0 Victory Tottenham for Over Arsenal

Football Fever Grips Hong Kong as nearly 50,000 Fans Pack Kai Tak Download high-resolution images:  HONG KONG, Aug. 1, 2025 /PRNewswire/ -- The Herbalgy Trophy: Arsenal vs...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers